FIELD: medicine.
SUBSTANCE: invention refers to medicine, and concerns a method of increasing body repair activity consisting in management of a wound with a wound healing formulation containing peptides used in a medicinal base. The peptides are presented by the peptides having the following structure LYS GLY PRO LEY THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO and THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO.
EFFECT: invention provides increasing repair activity in the relation to the wound process.
1 cl, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INCREASING PROLIFERATIVE ACTIVITY OF PERIPHERAL BLOOD LYMPHOCYTES | 2010 |
|
RU2465001C2 |
| METHOD OF INCREASING BACTERICIDAL ACTIVITY | 2010 |
|
RU2448725C2 |
| SYNTHETIC POLYPEPTIDE, METHOD FOR ITS PRODUCTION AND AGENT FOR CULTIVATION ON ITS BASE | 1994 |
|
RU2061699C1 |
| GROWTH STIMULATING AGENT FOR HUMAN BONE MARROW CELLS | 1994 |
|
RU2136308C1 |
| METHOD OF DIAGNOSIS OF HEMOPOIESIS DEPRESSION | 1994 |
|
RU2136307C1 |
| AGENT FOR TREATING PERIODONTITIS AND A METHOD OF TREATING PERIODONTITIS | 2020 |
|
RU2729428C1 |
| PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS | 2010 |
|
RU2627065C2 |
| METHOD OF CONTROL OF HEART RHYTHM AND REDUCTION OF INDIVIDUAL CARDIOMYOCYTES USING THERMOGENETICS | 2022 |
|
RU2802995C1 |
| VACCINE BASED ON AAV5 FOR INDUCTION OF SPECIFIC IMMUNITY TO SARS-CoV-2 VIRUS AND/OR PREVENTION OF CORONAVIRUS INFECTION CAUSED BY SARS-CoV-2 | 2020 |
|
RU2783313C1 |
| HIGH-PENETRATION PRODRUG COMPOSITIONS BASED ON PEPTIDES AND PEPTIDE-RELATED COMPOUNDS | 2010 |
|
RU2767051C2 |
